TGen to Evaluate Febit's DNA-Capture Arrays for Next-Gen Sequencing | GenomeWeb
NEW YORK (GenomeWeb News) – Febit said today that it will collaborate with the Translational Genomics Research Institute to evaluate the use of Febit’s Geniom microarray technology in capturing DNA for next-generation sequencers.
 
TGen is Febit’s first US pilot user for the HybSelect technology, which the company said enables selective DNA capture and elution in order to pre-select sequences for next-generation platforms.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.